The effectiveness of community-based visual screening and utility of adjunctive diagnostic aids in the early detection of oral cancer

Oral Oncology

Volumn 39, Issue 7, 2003, Pages 708-723

  Patton, Lauren L ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Cancer; Diagnosis computer assisted; Early detection; Mass screening; Mouth neoplasms; Oral; Oropharyngeal neoplasms; Sensitivity and specificity; Tolonium chloride

Indexed keywords

TOLONIUM CHLORIDE;

ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COMMUNITY CARE; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HIGH RISK POPULATION; HUMAN; MASS SCREENING; MOUTH CANCER; MOUTH EXAMINATION; PRIORITY JOURNAL;

EID: 0042202309     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(03)00083-6     Document Type: Article

References (54)

1. Jemal A., Thomas A., Murray T., Thun M. Cancer Statistics, 2002. CA Cancer J Clin. 52:2002;23-47.
2. Swango P.A. Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview. J Public Health Dent. 56:1996;309-318.
3. Malaowalla A.M., Silverman S., Mani N.J., Bilimoria K.F., Smith L.W. Oral cancer in 57,518 industrial workers of Gujarat, India: a prevalence and follow-up study. Cancer. 37:1976;1882-1886.
4. Mehta F.S., Gupta P.C., Bhonsle R.B., Murti P.R., Daftary D.K., Pindborg J.J. Detection of oral cancer using basic health workers in an area of high oral cancer incidence in India. Cancer Detection Prevention. 9:1986;219-225.
5. Bouquot J.E. Common oral lesions found during a mass screening examination. JADA. 112:1986;50-57.
6. Bouquot J.E., Gorlin R.J. Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years. Oral Surg Oral Med Oral Pathol. 61:1986;373-381.
7. Suggs T.F., Cable T.A., Rothenberger L.A. Results of a work-site educational and screening program for hypertension and cancer. J Occupational Med. 32:1990;220-225.
8. Warnakulasuriya S., Pindborg J.J. Reliability of oral precancer screening by primary health care workers in Sri Lanka. Community Dent Health. 7:1990;73-79.
9. Banoczy J., Rigo O. Prevalence study of oral precancerous lesions within a complex screening system in Hungary. Community Dent Oral Epidemiol. 19:1991;265-267.
10. Ikeda N., Ishii T., Iida S., Kawai T. Epidemiological study of oral leukoplakia based on mass screening for oral mucosal diseases in a selected Japanese population. Community Dent Oral Epidemiol. 19:1991;160-163.
11. Talamini R., Barzan L., Franceschi S., Caruso G., Gasparin A., Comoretto R. Determinants of compliance with an early detection programme for cancer of the head and neck in North-eastern Italy. Eur J Cancer Part B, Oral Oncol. 30B:1994;415-418.
12. Field E.A., Morrison T., Darling A.E., Parr T.A., Zakrzewska J.M. Oral mucosal screening as an integral part of routine dental care. Br Dent J. 179:1995;262-266.
13. Ikeda N., Downer M.C., Ishii T., Fukano H., Nagao T., Inoue K. Annual screening for oral cancer and precancer by invitation to 60-year-old residents of a city in Japan. Community Dental Health. 12:1995;133-137.
14. Fernandez Garrote L., Sankaranarayanan R., Lance Anta J.J., Rodriguez Salva A., Parkin D.M. An evaluation of the oral cancer control program in Cuba. Epidemiology. 6:1995;428-431.
15. Jullien J.A., Downer M.C., Zakrzewska J.M., Speight P.M. Evaluation of a screening test for the early detection of oral cancer and precancer. Community Dental Health. 12:1995;3-7.
16. Jullien J.A., Zakrzewska J.M., Downer M.C., Speight P.M. Attendance and compliance at an oral cancer screening programme in a general medical practice. Eur J Cancer Part B, Oral Oncol. 31B:1995;202-206.
17. Downer M.C., Evans A.W., Hughes Hallet C.M., Jullien J.A., Speight P.M., Zakrzewska J.M. Evaluation of screening for oral cancer and precancer in a company headquarters. Community Dent Oral Epidemiol. 23:1995;84-88.
18. Mathew B., Wesley R., Dutt S.C., Amma S., Sreekumar C. Cancer screening by local volunteers. World Health Forum. 17:1996;377-378.
19. Mathew B., Sankaranarayanan R., Sunilkumar K.B., Kuruvila B., Pisani P., Nair M.K. Reproducibility and validity of oral visual inspection by trained health workers in the detection of oral precancer and cancer. Brit J Cancer. 76:1997;390-394.
20. Burzynski N.J., Firriolo F.J., Butters J.M., Sorrell C.L. Evaluation of oral cancer screening. J Cancer Educ. 12:1997;95-99.
21. Prout M.N., Sidari J.N., Witzburg R.A., Grillone G.A., Vaughan C.W. Head and neck cancer screening among 4611 tobacco users older than forty years. Otolaryngology Head Neck Surg. 116:1997;201-208.
22. Sankaranarayanan R., Mathew B., Jacob B.J.et al. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer. 88:2000;664-673.
23. Nagao T., Ikeda N., Fukano H., Miyazaki H., Yano M., Warnakulasuriya S. Outcome following a population screening programme for oral cancer and precancer in Japan. Oral Oncol. 36:2000;340-346.
24. Nagao T., Warnakulasuriya S., Ikeda N., Fukano H., Fujiwara K., Miyazaki H. Oral cancer screening as an integral part of general health screening in Tokoname City, Japan. J Med Screen. 7:2000;203-208.
25. Vahidy N.A., Zaidi S.H.M., Jafarey N.A. Toluidine blue test for detection of carcinoma of the oral cavity: an evaluation. J Surg Oncol. 4:1972;434-438.
26. Mashberg A. Reevaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma. A continuing prospective study of oral cancer III. Cancer. 46:1980;758-763.
27. Mashberg A. Final evaluation of tolonium chloride rinse for screening of high-risk patients with asymptomatic squamous carcinoma. JADA. 106:1983;319-323.
28. Mashberg A. Tolonium (toluidine blue) rinse - a screening method for recognition of squamous carcinoma. Continuing study of oral cancer IV. JAMA. 245:1981;2408-2410.
29. Silverman S. Jr., Migliorati C., Barbosa J. Toluidine blue staining in the detection of oral precancerous and malignant lesions. Oral Surg Oral Med Oral Pathol. 57:1984;379-382.
30. Epstein J.B., Scully C., Spinelli J.J. Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med. 21:1992;160-163.
31. Speight P.M., Elliott A.E., Jullien J.A., Downer M.C., Zakzrewska J.M. The use of artificial intelligence to identify people at risk of oral cancer and precancer. Br Dent J. 179:1995;382-387.
32. Warnakulasuriya K.A., Johnson N.W. Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med. 25:1996;97-103.
33. Epstein J.B., Oakley C., Millner A., Emerton S., van der Meij E., Le N. The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 83:1997;537-547.
34. Sciubba J.J. US Collaborative OralCDx Study Group. Improving detection of precancerous and cancerous oral lesions. JADA. 130:1999;1445-1447.
35. Onofre M.A., Sposto M.R., Navarro C.M. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 91:2001;535-540.
36. Christian D.C. Computer-assisted analysis of oral brush biopsies at an oral cancer screening program. JADA. 133:2002;357-362.
37. Moore C., Greenberg R.A., Kane L. Feasibility study of a head and neck (upper aero-digestive tract) cancer examination. J Nat Cancer Institute. 79:1987;409-415.
38. van der Waal I., Axéll T. Oral leukoplakia: a proposal for uniform reporting. Oral Oncol. 38:2002;521-526.
39. Downer M.C., Jullien J.A., Speight P.M. An interim determination of health gain from oral cancer and precancer screening: 2. developing a model of population screening. Community Dental Health. 14:1997;227-232.
40. Downer M.C., Jullien J.A., Speight P.M. An interim determination of health gain from oral cancer and precancer screening: 3. preselecting high risk individuals. Community Dental Health. 15:1998;72-76.
41. Humphris G.M., Ireland R.S., Field E.A. Randomised trial of the psychological effect of information about oral cancer in primary care settings. Oral Oncol. 37:2001;548-552.
42. Blot W.J., McLaughlin J.K., Winn D.M.et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 48:1988;3282-3287.
43. Shiboski C.H., Shiboski S.C., Silverman S. Jr. Trends in oral cancer rates in the United States, 1973-1996. Community Dent Oral Epidemiol. 28:2000;249-256.
44. Pandey M., Thomas G., Somanathanm T.et al. Evaluation of surgical excision of non-homogeneous oral leukoplakia in a screening intervention trial, Kerala, India. Oral Oncol. 37:2001;103-109.
45. Lingen M.W. Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents. Crit Rev Oral Biol Med. 10:1999;153-164.
46. Klaassen I., Braakhuis B.J.M. Anticancer activity and mechanism of action of retinoids in oral and pharyngeal cancer. Oral Oncol. 38:2002;532-542.
47. Papadimitrakopoulou V.A., Clayman G.L., Shin D.M.et al. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg. 125:1999;1083-1089.
48. Franceschi S., Bidoli E., Herrero R., Muñoz N. Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol. 36:2000;106-115.
49. Parkin D.M., Muir C.S., Whelan S.L., Gao Y.-T., Ferlay J., Powell J. Cancer Incidence in Five Continents. Vol. 6 (IARC Scientific Publications No. 120). 1992;International Agency for Research on Cancer, Lyon.
50. Sankaranarayanan R., Fernandez-Garrote L., Lence-Anta J., Pisani P., Rodriguez-Salva A. Visual inspection in oral cancer screening in Cuba: a case-control study. Oral Oncology. 38:2002;131-136.
51. Friedrich R.E., Giese M., Riethdorf S., Loning T. P53-mutation in smears of oral squamous cell carcinoma. Anticancer Res. 20:2000;4927-4930.
52. Okazaki Y., Tanaka Y., Tonogi M., Yamane G. Investigation of environmental factors for diagnosing malignant potential in oral epithelial dysplasia. Oral Oncol. 38:2002;562-573.
53. Nunes D.N., Kowalski L.P., Simpson A.J.G. Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings. Oral Oncol. 36:2000;525-528.
54. Rosenberg D., Cretin S. Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol. 67:1989;621-627.